FFAR1 and type 2 diabetes mellitus: Because the GK rat is a lean insulin deficient rodent model of type 2 diabetes, we focused most of our studies on the pharmacological differences between GPR40 partial agonists and AgoPAMs on the hormonal and metabolic regulation of glucose homeostasis.